UPDATE: The 2026 Horizon – Rationalization, Rebound, and Regulation As we move further into the decade, the tentative optimism of 2025 has hardened into a landscape defined by “industrial maturity” and a decisive rebound in transaction activity. While 2025 was a year of preparation, 2026 is poised to accelerate activity across biopharma and healthcare services,…
The medical device and healthtech products market is growing faster than any other segment of the healthcare industry. In fact, it’s expected to double in size by 2025, accounting for 10% of all healthcare spending that year. We also see more and more healthcare startups launching new medical products every day. They’re a sign of…
It is amazing how time flies, and here we are at the Jewish new year again. As one year ends and we transition into another, we take this opportunity to send our wishes for a sweet, healthy and successful new year to all of our partners, colleagues, clients and friends who are celebrating. Shana Tova…
September, 2022 Aurore ANDRE, CEO of Azapharm joins the strategic board of Apmonia Therapeutics, a biotechnology company dedicated to developing anti-cancer immunotherapy strategies. Apmonia’s strategic board comprises experts in biotech, business, funding and more, who harness their experience to support the company’s innovation and growth. “I am pleased to welcome Aurore to our strategic board. We believe the experience and knowledge she brings…
A recent article, posted on Linkedin by Aurore Andre, CEO of Azapharm reviews the use of Artificial Intelligence in healthcare: pros, cons and the path forward. Artificial intelligence is one of the fastest-growing industries, with sector funding up by 108% in 2021. Among those investments and developments are applications for medical care and hospital administration.…
By: Katherine Wong-Selz Overview of the Horizon Europe Programme At the beginning of April, the European Commission launched the first calls for the Horizon Europe programme. Between now and 2027, it will provide nearly 100 billion € in research and innovation project funding to boost Europe’s research excellence and transform the fruits of that excellence…
It’s been a challenging year for everyone, but as the Beatles said “Here comes the sun, and I say it’s all right”. As we’re getting ready to celebrate Passover, the holiday of spring and freedom, we wish you and your loved ones a great break to recharge, regenerate and returned filled with hope. From all…
Digital Communication for Healthtech MedTech and Biotech companies: How things have changed and will change this year Digital communication is never as easy as it sounds. It’s not all about social media and content marketing. It is not about your website and the newsletters you send. These are all just tools. Digital communication is first…
2020 has been an eventful year for everyone but more so for the healthcare and healthtech sectors. We at Azapharm, have been keeping a close eye on the two ecosystems we are most close to and work with: Israel and France. Both countries have amazing groundbreaking innovation and they are pushing forward with full steam…
After an 11th hour deal struck for the next European Union budget by its 27 members on 10th December 2020, Horizon Europe, the EU’s latest research and innovation investment programme can at last be launched next month. Originally touted at 100-125 billion €, the Horizon Europe budget was pared back to 95.5 billion €, in…